Softwr

Healthcare · head to head

Meru Health vs Paige

Meru Health logo

Meru Health

Healthcare

Twelve week therapist led mental health programme combining an app, a clinician and HRV biofeedback

From
On request
Rated
-
Full reviewWebsite
Paige logo

Paige

Healthcare

Digital pathology AI holding the first FDA De Novo authorisation for a pathology algorithm, now part of Tempus

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Meru Health the programme is twelve weeks and then it ends, which fits an episode of treatment but not a chronic condition needing maintenance, so relapse after week twelve lands on whatever pathway the buyer has funded next, if any.; Paige the FDA authorisation is confined to prostate core needle biopsies, on compatible scanners, viewed through FullFocus, as an adjunct only; every other tissue type and every grading claim is outside that authorisation in the United States.
  • They diverge on capability: Meru Health covers Twelve week structured programme, Paige covers Paige Prostate Detect.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Meru Health and Paige actually diverge.

Attributes where Meru Health and Paige differ
AttributeMeru HealthPaige
PlatformsWeb, iOS, AndroidWeb, Cloud, On-premise

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Meru Health

  • Twelve week structured programme
  • Licensed therapist
  • Psychiatric consultation
  • HRV biofeedback device
  • Daily in app practice
  • Meru Health Advanced
  • Payer contracting
  • Outcome measurement

Only in Paige

  • Paige Prostate Detect
  • Paige Prostate Grade and Quantify
  • Perineural invasion detection
  • Breast and lymph node applications
  • FullFocus viewer
  • Foundation models
  • OmniScreen
  • Paige Alba

What people use each for

The jobs each tool is most often brought in to do.

Meru Health

  • A health plan that wants a mental health intervention it can underwrite as a bounded episode rather than an open ended benefitnot Paige
  • An employer whose staff need treatment rather than wellbeing content, with a therapist and a prescriber in one pathwaynot Paige
  • A member who needs medication review alongside therapy, which most app based mental health products cannot providenot Paige
  • A health system seeking to offload moderate depression and anxiety from a psychiatry service with long waitsnot Paige

Paige

  • A reference laboratory processing high volumes of prostate core needle biopsies where a second read on every case is not staffablenot Meru Health
  • A pathology department already digitised that wants a documented safety net against missed small foci of cancernot Meru Health
  • A hospital laboratory struggling to recruit uropathology subspecialists and needing consistency across generalist reportingnot Meru Health
  • A pharmaceutical company needing consistent biomarker scoring across trial sites rather than site-by-site pathologist variabilitynot Meru Health

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Meru Health

  • The programme is twelve weeks and then it ends, which fits an episode of treatment but not a chronic condition needing maintenance, so relapse after week twelve lands on whatever pathway the buyer has funded next, if any.
  • Whether the employer, the health plan or the member pays depends on the contract route, and members frequently do not know which applies to them until they receive a bill or discover they do not.
  • A structured programme demands daily engagement, and members who cannot sustain that get much less than the outcome data implies, because the published results reflect members who completed.
  • The heart rate variability device is a differentiator but also a logistics and support burden, adding shipping, returns and device support to what would otherwise be a software deployment.
  • Meru is small relative to Lyra, Spring Health and the large payer owned behavioural health offerings, so an employer choosing it takes on more vendor concentration risk in a category that has seen frequent consolidation.

Paige

  • The FDA authorisation is confined to prostate core needle biopsies, on compatible scanners, viewed through FullFocus, as an adjunct only; every other tissue type and every grading claim is outside that authorisation in the United States.
  • The algorithm is worthless without a digital pathology programme already running, and slide scanning, storage and workflow typically cost far more than the software licence.
  • Tempus acquired Paige in 2025, so the roadmap now competes for attention inside a genomics-led business, and the pathology-only buyer is no longer the primary customer.
  • Scanner compatibility is a hard constraint rather than a preference, and a laboratory with an unsupported scanner fleet cannot use the authorised indication at all.
  • Pricing is per case or per slide and unpublished, so a laboratory cannot model cost per reported case without entering a sales process.

Pricing, plan by plan

Meru Health

On request
  • Meru Health$undefined/year
    • Contracted per completed programme or per member per month depending on buyer type
    • Health plan contracts bill differently from employer contracts
    • Member cost sharing depends on whether access comes via insurance or an employer benefit

Paige

On request
  • Paige clinical applications$undefined/year
    • Priced per case or per slide analysed under annual agreement
    • Prostate, breast and other applications licensed separately
    • Requires compatible whole slide scanner and the FullFocus viewer for the authorised indication

Which should you pick?

Choose Meru Health if

  • You need twelve week structured programme.
  • You work on Web, iOS, Android.
  • You also want licensed therapist.
Meru Health review

Choose Paige if

  • You need paige prostate detect.
  • You work on Web, Cloud, On-premise.
  • You also want paige prostate grade and quantify.
Paige review

Questions people ask

Is Meru Health or Paige better?
Neither clearly leads. Meru Health starts at On request and Paige at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Meru Health or Paige?
Meru Health starts at On request and Paige at On request.
Does Meru Health or Paige run on more platforms?
Meru Health runs on Web, iOS, Android. Paige runs on Web, Cloud, On-premise.
What is Meru Health best used for?
Meru Health is most often used for a health plan that wants a mental health intervention it can underwrite as a bounded episode rather than an open ended benefit, an employer whose staff need treatment rather than wellbeing content, with a therapist and a prescriber in one pathway, a member who needs medication review alongside therapy, which most app based mental health products cannot provide, a health system seeking to offload moderate depression and anxiety from a psychiatry service with long waits. Of those, a health plan that wants a mental health intervention it can underwrite as a bounded episode rather than an open ended benefit and an employer whose staff need treatment rather than wellbeing content, with a therapist and a prescriber in one pathway are not what Paige is typically brought in for.
What can Meru Health do that Paige cannot?
Meru Health covers Twelve week structured programme, Licensed therapist, Psychiatric consultation, HRV biofeedback device. Paige covers Paige Prostate Detect, Paige Prostate Grade and Quantify, Perineural invasion detection, Breast and lymph node applications.

Answered from the vendors’ own pages

Meru Health: Is Meru Health still operating?

Yes. It launched Meru Health Advanced in May 2026 and expanded its Harvard Pilgrim Health Care collaboration in 2025. It has not wound down.

Paige: What exactly is FDA authorised?

Paige Prostate Detect, as an adjunct for identifying areas of interest on digitised prostate core needle biopsy slides, viewed through the Paige FullFocus viewer on a compatible scanner. Nothing else in the portfolio holds that authorisation in the United States.

Meru Health: How long is the programme?

Around twelve weeks. It is a bounded treatment episode rather than open ended therapy, which is why health plans will contract for it.

Paige: Is the European position broader?

Yes. The Paige Prostate suite including grading and quantification received IVDR certification in 2025, which covers more than the United States authorisation.

Meru Health: Who pays?

It depends on the contract. Meru sells to both health plans and employers, and member cost sharing differs between those routes. Confirm which applies before enrolling.

Paige: What did the pivotal study measure?

Pathologist cancer detection on individual slide images improved, with reported reductions in false negative and false positive readings. It measured pathologist performance with the tool, not standalone algorithm accuracy.

Meru Health: Does it include medication?

Psychiatric consultation is part of the programme where medication is indicated, which distinguishes it from app plus coaching products that cannot prescribe.

Paige: Who owns Paige now?

Tempus AI acquired Paige in 2025. Products remain branded Paige.

Share

Related pages

More on Meru Health

More on Paige

Keep looking

Other head to heads